https://www.selleckchem.com/products/Nolvadex.html
5-ALA at 10%-30% concentration is safe in patients with CIN. For further treatment, we recommend the application of 20% 5-ALA, 6 hours before photodynamic therapy in CIN. This study was registered at http//www.chinadrugtrials.org.cn (registration number CTR20130326) in accordance with the requirements of the National Medical Products Administration in China. Considering that there is no English version of the above website, we made a retrospective registration on http//www.chictr.org.cn (registration number ChiCTR1800016755) in 2018. L
Curtir
Comentario
Compartilhar
